Cinclus Pharma
Cinclus Pharma AG is a research based biotech company
Cinclus Pharma has raised €71M across 2 funding rounds from 3 investors, most recently a round in May 2022. Based in Mölndal, Sweden; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€71M
€71,101,209
Funding rounds
2
Investors
3
distinct backers
Active since
2020-05
latest 2022-05
Funding by year
EUR raised per yearCinclus Pharma — funding by year — interactive chart.
Data table
| Cinclus Pharma — funding by year | |
|---|---|
| 2020 | €23M |
| 2022 | €48M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-20 | Other | €48M | EIR Ventures,Fjärde AP-Fonden,Trill Impact Ventures | View deal → |
| 2020-05-03 | Other | €23M | — | View deal → |